NFKB1 and ovarian carcinoma: Overall, DHA has been investigated more in ovarian cancer, with many reports showing DHA inhibiting ovarian cancer in vitro and in vivo by modulating the oncogenic signaling of NFkB and MAPK pathways, PPARγ activation, ROS activation, and potentiating chemotherapy [51,92,93].